Question 1

What is Appili Therapeutics?

Accepted Answer

Appili Therapeutics is a Company.

Question 2

How often does Appili Therapeutics appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 7 articles.

Question 3

When was Appili Therapeutics first tracked by Ergen?

Accepted Answer

First tracked on Jul 03, 2026.

Question 4

When was Appili Therapeutics last mentioned in news?

Accepted Answer

Last active on Jul 04, 2026.

Question 5

What is Appili Therapeutics's current news sentiment?

Accepted Answer

Aggregate sentiment score: -70 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Appili Therapeutics in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Appili Therapeutics?

Accepted Answer

Appili Therapeutics VXV-01 Contract Terminated (Jul 03, 2026, 7 articles).

Question 8

How did the "Appili Therapeutics VXV-01 Contract Terminated" event impact Appili Therapeutics?

Accepted Answer

Appili Therapeutics received a termination notice for a significant contract, impacting its VXV-01 fungal vaccine candidate program and potentially its financial outlook. The company is assessing the implications and focusing on other assets like ATI-1801 and LIKMEZ®.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.